Results of a study comparing acalabrutinib versus chlorambucil with rituximab for first line CLL.
Home / Resource Library / Acalabrutinib vs chlorambucil plus rituximab in untreated chronic lymphocytic leukemia: A randomized phase 3 Asian study
Results of a study comparing acalabrutinib versus chlorambucil with rituximab for first line CLL.